Results 41 to 50 of about 10,100 (210)

HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells

open access: yesCell Reports, 2019
Summary: Mucosal immune responses to HIV-1 involve the recognition of the viral envelope glycoprotein (gp)160 by tissue-resident B cells and subsequent secretion of antibodies.
Cyril Planchais   +15 more
doaj   +1 more source

Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.

open access: yesPLoS Pathogens, 2023
Recent HIV-1 vaccine development has centered on "near native" soluble envelope glycoprotein (Env) trimers that are artificially stabilized laterally (between protomers) and apically (between gp120 and gp41).
Tommy Tong   +7 more
doaj   +1 more source

Development and evaluation of a differential diagnostic test strip for antibodies induced by HIV-1 vaccine and natural infections

open access: yesDi-san junyi daxue xuebao, 2019
Objective To develop a differential diagnostic kit for distinguishing antibodies induced by HIV-1 infection and HIV-1 vaccine and evaluate its diagnostic performance.
YUAN Zuowei   +3 more
doaj   +1 more source

HIV-1 Envelope Glycoprotein Amino Acids Signatures Associated with Clade B Transmitted/Founder and Recent Viruses

open access: yesViruses, 2019
Background: HIV-1 transmitted/founder viruses (TF) are selected during the acute phase of infection from a multitude of virions present during transmission.
Alexis Kafando   +11 more
doaj   +1 more source

Analysis of the subunit stoichiometries in viral entry. [PDF]

open access: yesPLoS ONE, 2012
Virions of the Human Immunodeficiency Virus (HIV) infect cells by first attaching with their surface spikes to the CD4 receptor on target cells. This leads to conformational changes in the viral spikes, enabling the virus to engage a coreceptor, commonly
Carsten Magnus, Roland R Regoes
doaj   +1 more source

Surfactant protein D inhibits HIV-1 infection of target cells via interference with gp120-CD4 interaction and modulates pro-inflammatory cytokine production [PDF]

open access: yes, 2014
© 2014 Pandit et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are ...
Al-Mozaini, MA   +52 more
core   +1 more source

Modulation of cytokine release and gene expression by the immunosuppressive domain of gp41 of HIV-1.

open access: yesPLoS ONE, 2013
The transmembrane envelope protein gp41 of the human immunodeficiency virus HIV-1 plays an important role during infection allowing fusion of the viral and cellular membrane.
Joachim Denner   +6 more
doaj   +1 more source

Multimeric scaffolds displaying the HIV-1 envelope MPER induce MPER-specific antibodies and cross-neutralizing antibodies when co-immunized with gp160 DNA. [PDF]

open access: yesPLoS ONE, 2014
Developing a vaccine that overcomes the diversity of HIV-1 is likely to require a strategy that directs antibody (Ab) responses toward conserved regions of the viral Envelope (Env).
Shelly J Krebs   +11 more
doaj   +1 more source

Immunisation with the membrane proximal external region of gp41 of HIV-1 grafted into the transmembrane envelope protein of a gammaretrovirus [PDF]

open access: yesRetrovirology, 2012
Background Immunisation with the transmembrane envelope (TM) proteins p15E of different gammaretroviruses (e.g., porcine endogenous retrovirus, feline leukaemia virus, Koala retrovirus) resulted in strong neutralising activity, the antibodies recognised epitopes in the fusion peptide proximal region (FPPR) and in the membrane proximal external region ...
Strasz, N.   +4 more
openaire   +3 more sources

Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection

open access: yesVirology Journal, 2008
Background The high diversity of HIV variants driving the global AIDS epidemic has caused many to doubt whether an effective vaccine against the virus is possible.
Karim Salim   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy